Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Recombinant Glycoprotein E of Varicella Zoster Virus Contains Glycan-Peptide Motifs That Modulate B Cell Epitopes into Discrete Immunological Signatures.

Nordén R, Nilsson J, Samuelsson E, Risinger C, Sihlbom C, Blixt O, Larson G, Olofsson S, Bergström T.

Int J Mol Sci. 2019 Feb 22;20(4). pii: E954. doi: 10.3390/ijms20040954.

2.

Characterization of avian influenza virus attachment patterns to human and pig tissues.

Eriksson P, Lindskog C, Engholm E, Blixt O, Waldenström J, Munster V, Lundkvist Å, Olsen B, Jourdain E, Ellström P.

Sci Rep. 2018 Aug 15;8(1):12215. doi: 10.1038/s41598-018-29578-1.

3.

ABO Blood Group Antigen Decorated Giant Unilamellar Vesicles Exhibit Distinct Interactions with Plasmodium falciparum Infected Red Blood Cells.

Vagianou CD, Stuhr-Hansen N, Moll K, Bovin N, Wahlgren M, Blixt O.

ACS Chem Biol. 2018 Sep 21;13(9):2421-2426. doi: 10.1021/acschembio.8b00635. Epub 2018 Aug 13.

PMID:
30080386
4.

Epitope-mapping of the glycoprotein from Crimean-Congo hemorrhagic fever virus using a microarray approach.

Fritzen A, Risinger C, Korukluoglu G, Christova I, Corli Hitzeroth A, Viljoen N, Burt FJ, Mirazimi A, Blixt O.

PLoS Negl Trop Dis. 2018 Jul 9;12(7):e0006598. doi: 10.1371/journal.pntd.0006598. eCollection 2018 Jul.

5.

Effect of Noncanonical Amino Acids on Protein-Carbohydrate Interactions: Structure, Dynamics, and Carbohydrate Affinity of a Lectin Engineered with Fluorinated Tryptophan Analogs.

Tobola F, Lelimousin M, Varrot A, Gillon E, Darnhofer B, Blixt O, Birner-Gruenberger R, Imberty A, Wiltschi B.

ACS Chem Biol. 2018 Aug 17;13(8):2211-2219. doi: 10.1021/acschembio.8b00377. Epub 2018 Jun 12.

6.

Application of lectin microarrays for the analysis of seminal plasma glycome.

Kołodziejczyk J, Blixt O, Olejnik B, Zimmer M, Ferens-Sieczkowska M.

Andrologia. 2018 Aug;50(6):e13018. doi: 10.1111/and.13018. Epub 2018 Apr 17.

PMID:
29665136
7.

Repertoire of Abs primed by bacteria in gnotobiotic mice.

Khasbiullina NR, Shilova NV, Navakouski ME, Nokel AY, Knirel YA, Blixt O, Bovin NV.

Innate Immun. 2018 Apr;24(3):180-187. doi: 10.1177/1753425918763524. Epub 2018 Mar 16.

PMID:
29546786
8.

A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer.

Wendel U, Persson N, Risinger C, Bengtsson E, Nodin B, Danielsson L, Welinder C, Nordin Fredrikson G, Jansson B, Blixt O.

PLoS One. 2018 Feb 8;13(2):e0191872. doi: 10.1371/journal.pone.0191872. eCollection 2018.

9.

Synthesis of Oligo-(alkyne-triplet)peptide Constructs.

Stuhr-Hansen N, Risinger C, Engholm E, Blixt O.

Org Lett. 2017 Dec 15;19(24):6522-6525. doi: 10.1021/acs.orglett.7b03231. Epub 2017 Dec 5.

PMID:
29205042
10.

Synthesis of BODIPY-Labeled Cholesterylated Glycopeptides by Tandem Click Chemistry for Glycocalyxification of Giant Unilamellar Vesicles (GUVs).

Stuhr-Hansen N, Vagianou CD, Blixt O.

Chemistry. 2017 Jul 18;23(40):9472-9476. doi: 10.1002/chem.201702104. Epub 2017 Jun 22.

PMID:
28513898
11.

Epitope mapping of a new anti-Tn antibody detecting gastric cancer cells.

Persson N, Stuhr-Hansen N, Risinger C, Mereiter S, Polónia A, Polom K, Kovács A, Roviello F, Reis CA, Welinder C, Danielsson L, Jansson B, Blixt O.

Glycobiology. 2017 Jul 1;27(7):635-645. doi: 10.1093/glycob/cwx033.

PMID:
28419225
12.

Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.

Hinkula J, Devignot S, Åkerström S, Karlberg H, Wattrang E, Bereczky S, Mousavi-Jazi M, Risinger C, Lindegren G, Vernersson C, Paweska J, van Vuren PJ, Blixt O, Brun A, Weber F, Mirazimi A.

J Virol. 2017 Apr 28;91(10). pii: e02076-16. doi: 10.1128/JVI.02076-16. Print 2017 May 15.

13.

Optimization of the Small Glycan Presentation for Binding a Tumor-Associated Antibody: Application to the Construction of an Ultrasensitive Glycan Biosensor.

Kveton F, Blšáková A, Hushegyi A, Damborsky P, Blixt O, Jansson B, Tkac J.

Langmuir. 2017 Mar 21;33(11):2709-2716. doi: 10.1021/acs.langmuir.6b04021. Epub 2017 Mar 8.

14.

Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections.

Risinger C, Sørensen KK, Jensen KJ, Olofsson S, Bergström T, Blixt O.

ACS Infect Dis. 2017 May 12;3(5):360-367. doi: 10.1021/acsinfecdis.7b00001. Epub 2017 Mar 6.

PMID:
28238255
15.

A Combinatory Antibody-Antigen Microarray Assay for High-Content Screening of Single-Chain Fragment Variable Clones from Recombinant Libraries.

Persson N, Jansson B, Stuhr-Hansen N, Kovács A, Welinder C, Danielsson L, Blixt O.

PLoS One. 2016 Dec 21;11(12):e0168761. doi: 10.1371/journal.pone.0168761. eCollection 2016.

16.

Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.

Welinder C, Jirström K, Lehn S, Nodin B, Marko-Varga G, Blixt O, Danielsson L, Jansson B.

Heliyon. 2016 Aug 16;2(8):e00143. doi: 10.1016/j.heliyon.2016.e00143. eCollection 2016 Aug.

17.

Synthesis of Cholesterol-Substituted Glycopeptides for Tailor-Made Glycocalyxification of Artificial Membrane Systems.

Stuhr-Hansen N, Madl J, Villringer S, Aili U, Römer W, Blixt O.

Chembiochem. 2016 Aug 3;17(15):1403-6. doi: 10.1002/cbic.201600258. Epub 2016 Jun 17.

PMID:
27168414
18.

Cytotoxic activity against human neuroblastoma and melanoma cells mediated by IgM antibodies derived from peripheral blood of healthy donors.

Devarapu SK, Mamidi S, Plöger F, Dill O, Blixt O, Kirschfink M, Schwartz-Albiez R.

Int J Cancer. 2016 Jun 15;138(12):2963-73. doi: 10.1002/ijc.30025. Epub 2016 Feb 23.

19.

Viral O-GalNAc peptide epitopes: a novel potential target in viral envelope glycoproteins.

Olofsson S, Blixt O, Bergström T, Frank M, Wandall HH.

Rev Med Virol. 2016 Jan;26(1):34-48. doi: 10.1002/rmv.1859. Epub 2015 Nov 2. Review.

PMID:
26524377
20.

A novel monoclonal antibody to a defined peptide epitope in MUC16.

Marcos-Silva L, Ricardo S, Chen K, Blixt O, Arigi E, Pereira D, Høgdall E, Mandel U, Bennett EP, Vakhrushev SY, David L, Clausen H.

Glycobiology. 2015 Nov;25(11):1172-82. doi: 10.1093/glycob/cwv056. Epub 2015 Jul 22.

PMID:
26201951
21.

RIFINs are adhesins implicated in severe Plasmodium falciparum malaria.

Goel S, Palmkvist M, Moll K, Joannin N, Lara P, Akhouri RR, Moradi N, Öjemalm K, Westman M, Angeletti D, Kjellin H, Lehtiö J, Blixt O, Ideström L, Gahmberg CG, Storry JR, Hult AK, Olsson ML, von Heijne G, Nilsson I, Wahlgren M.

Nat Med. 2015 Apr;21(4):314-7. doi: 10.1038/nm.3812. Epub 2015 Mar 9.

PMID:
25751816
22.

A diverse range of bacterial and eukaryotic chitinases hydrolyzes the LacNAc (Galβ1-4GlcNAc) and LacdiNAc (GalNAcβ1-4GlcNAc) motifs found on vertebrate and insect cells.

Frederiksen RF, Yoshimura Y, Storgaard BG, Paspaliari DK, Petersen BO, Chen K, Larsen T, Duus JØ, Ingmer H, Bovin NV, Westerlind U, Blixt O, Palcic MM, Leisner JJ.

J Biol Chem. 2015 Feb 27;290(9):5354-66. doi: 10.1074/jbc.M114.607291. Epub 2015 Jan 5.

23.

Arraying the post-translational glycoproteome (PTG).

Blixt O, Westerlind U.

Curr Opin Chem Biol. 2014 Feb;18:62-9. doi: 10.1016/j.cbpa.2014.01.002. Epub 2014 Jan 30. Review.

PMID:
24487061
24.

Lipochitin oligosaccharides immobilized through oximes in glycan microarrays bind LysM proteins.

Maolanon NN, Blaise M, Sørensen KK, Thygesen MB, Cló E, Sullivan JT, Ronson CW, Stougaard J, Blixt O, Jensen KJ.

Chembiochem. 2014 Feb 10;15(3):425-34. doi: 10.1002/cbic.201300520. Epub 2014 Jan 16.

PMID:
24436194
25.

Human tandem-repeat-type galectins bind bacterial non-βGal polysaccharides.

Knirel YA, Gabius HJ, Blixt O, Rapoport EM, Khasbiullina NR, Shilova NV, Bovin NV.

Glycoconj J. 2014 Jan;31(1):7-12. doi: 10.1007/s10719-013-9497-3. Epub 2013 Sep 25.

PMID:
24065176
26.

Synthesis of O-glycopeptides and construction of glycopeptide microarrays.

Blixt O, Cló E.

Methods Mol Biol. 2013;1047:201-14. doi: 10.1007/978-1-62703-544-6_14.

PMID:
23943488
27.

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer.

Burford B, Gentry-Maharaj A, Graham R, Allen D, Pedersen JW, Nudelman AS, Blixt O, Fourkala EO, Bueti D, Dawnay A, Ford J, Desai R, David L, Trinder P, Acres B, Schwientek T, Gammerman A, Reis CA, Silva L, Osório H, Hallett R, Wandall HH, Mandel U, Hollingsworth MA, Jacobs I, Fentiman I, Clausen H, Taylor-Papadimitriou J, Menon U, Burchell JM.

Br J Cancer. 2013 May 28;108(10):2045-55. doi: 10.1038/bjc.2013.214. Epub 2013 May 7.

28.

Primary breast cancer tumours contain high amounts of IgA1 immunoglobulin: an immunohistochemical analysis of a possible carrier of the tumour-associated Tn antigen.

Welinder C, Baldetorp B, Blixt O, Grabau D, Jansson B.

PLoS One. 2013 Apr 18;8(4):e61749. doi: 10.1371/journal.pone.0061749. Print 2013.

29.

Microarray Glycoprofiling of CA125 improves differential diagnosis of ovarian cancer.

Chen K, Gentry-Maharaj A, Burnell M, Steentoft C, Marcos-Silva L, Mandel U, Jacobs I, Dawnay A, Menon U, Blixt O.

J Proteome Res. 2013 Mar 1;12(3):1408-18. doi: 10.1021/pr3010474. Epub 2013 Feb 19.

PMID:
23360124
30.

Diverse IgG serum response to novel glycopeptide epitopes detected within immunodominant stretches of Epstein-Barr virus glycoprotein 350/220: diagnostic potential of O-glycopeptide microarrays.

D'Arrigo I, Cló E, Bergström T, Olofsson S, Blixt O.

Glycoconj J. 2013 Oct;30(7):633-40. doi: 10.1007/s10719-012-9465-3. Epub 2013 Jan 8.

PMID:
23292036
31.

Carbohydrate microarrays.

Park S, Gildersleeve JC, Blixt O, Shin I.

Chem Soc Rev. 2013 May 21;42(10):4310-26. doi: 10.1039/c2cs35401b. Epub 2012 Nov 28. Review.

PMID:
23192235
32.

Fine specificity and cross-reactions of monoclonal antibodies to group B streptococcal capsular polysaccharide type III.

Pincus SH, Moran E, Maresh G, Jennings HJ, Pritchard DG, Egan ML, Blixt O.

Vaccine. 2012 Jul 6;30(32):4849-58. doi: 10.1016/j.vaccine.2012.05.006. Epub 2012 May 23.

33.

Characterization of the viral O-glycopeptidome: a novel tool of relevance for vaccine design and serodiagnosis.

Cló E, Kracun SK, Nudelman AS, Jensen KJ, Liljeqvist JÅ, Olofsson S, Bergström T, Blixt O.

J Virol. 2012 Jun;86(11):6268-78. doi: 10.1128/JVI.00392-12. Epub 2012 Apr 4.

34.

Printed glycan array: antibodies as probed in undiluted serum and effects of dilution.

Shilova N, Navakouski M, Khasbiullina N, Blixt O, Bovin N.

Glycoconj J. 2012 Apr;29(2-3):87-91. doi: 10.1007/s10719-011-9368-8. Epub 2012 Jan 19.

PMID:
22258790
35.

Analysis of Tn antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells.

Blixt O, Lavrova OI, Mazurov DV, Cló E, Kracun SK, Bovin NV, Filatov AV.

Glycobiology. 2012 Apr;22(4):529-42. doi: 10.1093/glycob/cwr178. Epub 2011 Dec 5.

36.

Design of a covalently bonded glycosphingolipid microarray.

Arigi E, Blixt O, Buschard K, Clausen H, Levery SB.

Glycoconj J. 2012 Jan;29(1):1-12. doi: 10.1007/s10719-011-9359-9. Epub 2011 Nov 22.

PMID:
22102144
37.

In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity.

Chen LM, Blixt O, Stevens J, Lipatov AS, Davis CT, Collins BE, Cox NJ, Paulson JC, Donis RO.

Virology. 2012 Jan 5;422(1):105-13. doi: 10.1016/j.virol.2011.10.006. Epub 2011 Nov 5. Erratum in: Virology. 2012 Mar 15;424(2):154.

38.

Changes in the repertoire of natural antibodies caused by immunization with bacterial antigens.

Shilova NV, Navakouski MJ, Huflejt M, Kuehn A, Grunow R, Blixt O, Bovin NV.

Biochemistry (Mosc). 2011 Jul;76(7):862-6. doi: 10.1134/S0006297911070170.

PMID:
21999548
39.

Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity.

Pedersen JW, Bennett EP, Schjoldager KT, Meldal M, Holmér AP, Blixt O, Cló E, Levery SB, Clausen H, Wandall HH.

J Biol Chem. 2011 Sep 16;286(37):32684-96. doi: 10.1074/jbc.M111.273722. Epub 2011 Jul 15.

40.

Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses.

Maines TR, Chen LM, Van Hoeven N, Tumpey TM, Blixt O, Belser JA, Gustin KM, Pearce MB, Pappas C, Stevens J, Cox NJ, Paulson JC, Raman R, Sasisekharan R, Katz JM, Donis RO.

Virology. 2011 Apr 25;413(1):139-47. doi: 10.1016/j.virol.2011.02.015. Epub 2011 Mar 23.

41.

Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.

Blixt O, Bueti D, Burford B, Allen D, Julien S, Hollingsworth M, Gammerman A, Fentiman I, Taylor-Papadimitriou J, Burchell JM.

Breast Cancer Res. 2011 Mar 8;13(2):R25. doi: 10.1186/bcr2841.

42.

Seromic profiling of colorectal cancer patients with novel glycopeptide microarray.

Pedersen JW, Blixt O, Bennett EP, Tarp MA, Dar I, Mandel U, Poulsen SS, Pedersen AE, Rasmussen S, Jess P, Clausen H, Wandall HH.

Int J Cancer. 2011 Apr 15;128(8):1860-71. doi: 10.1002/ijc.25778. Epub 2011 Jan 12.

43.

Random glycopeptide bead libraries for seromic biomarker discovery.

Kracun SK, Cló E, Clausen H, Levery SB, Jensen KJ, Blixt O.

J Proteome Res. 2010 Dec 3;9(12):6705-14. doi: 10.1021/pr1008477. Epub 2010 Nov 2.

44.

O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids.

Schjoldager KT, Vester-Christensen MB, Bennett EP, Levery SB, Schwientek T, Yin W, Blixt O, Clausen H.

J Biol Chem. 2010 Nov 19;285(47):36293-303. doi: 10.1074/jbc.M110.156950. Epub 2010 Sep 13.

45.

A high-throughput O-glycopeptide discovery platform for seromic profiling.

Blixt O, Cló E, Nudelman AS, Sørensen KK, Clausen T, Wandall HH, Livingston PO, Clausen H, Jensen KJ.

J Proteome Res. 2010 Oct 1;9(10):5250-61. doi: 10.1021/pr1005229. Erratum in: J Proteome Res. 2011 Mar 4;10(3):1436.

46.

Characterization of an immunodominant cancer-specific O-glycopeptide epitope in murine podoplanin (OTS8).

Steentoft C, Schjoldager KT, Cló E, Mandel U, Levery SB, Pedersen JW, Jensen K, Blixt O, Clausen H.

Glycoconj J. 2010 Aug;27(6):571-82. doi: 10.1007/s10719-010-9301-6. Epub 2010 Aug 19.

PMID:
20721622
47.

Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.

Wandall HH, Blixt O, Tarp MA, Pedersen JW, Bennett EP, Mandel U, Ragupathi G, Livingston PO, Hollingsworth MA, Taylor-Papadimitriou J, Burchell J, Clausen H.

Cancer Res. 2010 Feb 15;70(4):1306-13. doi: 10.1158/0008-5472.CAN-09-2893. Epub 2010 Feb 2.

48.

Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity.

Stevens J, Blixt O, Chen LM, Donis RO, Paulson JC, Wilson IA.

J Mol Biol. 2008 Sep 19;381(5):1382-94. doi: 10.1016/j.jmb.2008.04.016. Epub 2008 Apr 11.

49.

Biocompatible carbon nanotubes generated by functionalization with glycodendrimers.

Wu P, Chen X, Hu N, Tam UC, Blixt O, Zettl A, Bertozzi CR.

Angew Chem Int Ed Engl. 2008;47(27):5022-5. doi: 10.1002/anie.200705363. No abstract available.

50.

Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility.

Belser JA, Blixt O, Chen LM, Pappas C, Maines TR, Van Hoeven N, Donis R, Busch J, McBride R, Paulson JC, Katz JM, Tumpey TM.

Proc Natl Acad Sci U S A. 2008 May 27;105(21):7558-63. doi: 10.1073/pnas.0801259105. Epub 2008 May 27.

Supplemental Content

Support Center